GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » EV-to-FCF

Adlai Nortye (Adlai Nortye) EV-to-FCF : -8.67 (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Adlai Nortye's Enterprise Value is $159.62 Mil. Adlai Nortye's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was $-18.41 Mil. Therefore, Adlai Nortye's EV-to-FCF for today is -8.67.

The historical rank and industry rank for Adlai Nortye's EV-to-FCF or its related term are showing as below:

ANL' s EV-to-FCF Range Over the Past 10 Years
Min: -26.03   Med: 0   Max: 0
Current: -8.67

ANL's EV-to-FCF is ranked worse than
100% of 379 companies
in the Biotechnology industry
Industry Median: 8.31 vs ANL: -8.67

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Adlai Nortye's stock price is $6.32. Adlai Nortye's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-2.125. Therefore, Adlai Nortye's PE Ratio for today is At Loss.


Adlai Nortye EV-to-FCF Historical Data

The historical data trend for Adlai Nortye's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye EV-to-FCF Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
EV-to-FCF
- - -4.66

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial - - - - -

Competitive Comparison of Adlai Nortye's EV-to-FCF

For the Biotechnology subindustry, Adlai Nortye's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adlai Nortye's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adlai Nortye's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Adlai Nortye's EV-to-FCF falls into.



Adlai Nortye EV-to-FCF Calculation

Adlai Nortye's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=159.617/-18.408
=-8.67

Adlai Nortye's current Enterprise Value is $159.62 Mil.
Adlai Nortye's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adlai Nortye  (NAS:ANL) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Adlai Nortye's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.32/-2.125
=At Loss

Adlai Nortye's share price for today is $6.32.
Adlai Nortye's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.125.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Adlai Nortye EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Adlai Nortye (Adlai Nortye) Business Description

Traded in Other Exchanges
Address
685 US Highway 1, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. The company has robust pipeline of drug candidates it includes buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as four preclinical candidates.

Adlai Nortye (Adlai Nortye) Headlines